ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202. A total of 35 filers reported holding ATYR PHARMA INC in Q3 2022. The put-call ratio across all filers is 5.23 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $18,757 | -96.9% | 8,565 | -95.7% | 0.00% | -100.0% |
| Q3 2022 | $604,000 | -43.0% | 201,361 | -46.2% | 0.00% | -33.3% |
| Q2 2022 | $1,060,000 | -68.3% | 374,395 | -40.1% | 0.01% | -68.4% |
| Q1 2022 | $3,344,000 | -28.4% | 625,000 | 0.0% | 0.02% | -17.4% |
| Q4 2021 | $4,669,000 | -17.7% | 625,000 | 0.0% | 0.02% | -8.0% |
| Q3 2021 | $5,675,000 | – | 625,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Telemetry Investments, L.L.C. | 282,420 | $1,511,000 | 2.38% |
| Tikvah Management LLC | 1,350,833 | $7,227,000 | 2.31% |
| Stonepine Capital Management, LLC | 601,580 | $3,218,000 | 1.34% |
| VR Adviser, LLC | 1,398,889 | $7,484,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $5,957,000 | 1.19% |
| Deep Track Capital, LP | 1,028,515 | $5,503,000 | 0.35% |
| FEDERATED HERMES, INC. | 5,222,250 | $27,939,000 | 0.06% |
| Alyeska Investment Group, L.P. | 760,798 | $4,070,000 | 0.04% |
| Ikarian Capital, LLC | 37,017 | $197,000 | 0.03% |
| Baker Brothers Advisors | 625,000 | $3,344,000 | 0.02% |